Health and Healthcare
Teva Pharmaceutical Shares Plunge on CEO Resignation
Published:
Last Updated:
After denying rumors earlier this week that its CEO was considering resigning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Wednesday morning that President and Chief Executive Jeremy Levin indeed will depart from the company. Levin has been CEO since May of 2012.
Chief Financial Officer Eyal Desheh will serve as president and CEO of Teva on an interim basis, effective immediately, the company said. Desheh has been with Teva for 12 years.
The Israel-based generic-drug maker announced earlier this month its plans to reduce its global workforce by 10%, or about 5,000 employees, part of a cost-cutting plan as it prepares for lower-priced competition to its best-selling multiple sclerosis drug, Copaxone. Teva’s sales and earnings have declined this year, in part due to weakness in its core generics business in the United States and Europe.
“I categorically deny the rumours suggesting that I am considering resigning from the management of Teva,” Levin said on Monday, following reports of strong differences of opinion between Levin and Chairman Phillip Frost over the implementation of Teva’s new strategy. But that was then.
The company is scheduled to report its third-quarter results on Thursday. The consensus forecast calls for $1.26 per share in earnings and $5.00 billion in revenue. That compares to $1.28 per share on $4.97 billion in the same period of last year. On Tuesday, CNBC’s Jim Cramer advised investors to take profits.
But the share price was down about 5% in premarket trading Wednesday to $39.00. The 52-week range is $36.63 to $42.83. Analysts had a mean price target of $44.16 before this news broke.
After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.
A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.
Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.